Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-05-10
2011-05-10
Goddard, Laura B (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
07939251
ABSTRACT:
The present invention provides methods of detecting cancer cells by detecting the quantity of SENP1 and/or telomerase in a sample.
REFERENCES:
patent: 5487972 (1996-01-01), Gelfand et al.
patent: 5837453 (1998-11-01), Harley et al.
patent: 5846723 (1998-12-01), Kim et al.
patent: 6551774 (2003-04-01), West et al.
patent: 6582904 (2003-06-01), Dahm
patent: 6596527 (2003-07-01), Yeh et al.
patent: 6607898 (2003-08-01), Kopreski et al.
patent: 2003/0045491 (2003-03-01), Reinhard et al.
patent: 2003/0170631 (2003-09-01), Houghton et al.
patent: 2004/0029114 (2004-02-01), Mack et al.
patent: 2004/0076955 (2004-04-01), Mack et al.
patent: 2006/0057623 (2006-03-01), Yeh
patent: 1 108 789 (2001-06-01), None
patent: 09100310 (2009-09-01), None
patent: 2003-506032 (2003-02-01), None
patent: WO 00/79267 (2000-12-01), None
patent: WO 01/09292 (2001-02-01), None
patent: WO 01/09292 (2001-02-01), None
patent: WO 01/09292 (2001-02-01), None
patent: WO 01/22920 (2001-04-01), None
patent: WO 2004/031411 (2004-04-01), None
patent: WO 2004/031412 (2004-04-01), None
patent: WO 2004/031412 (2004-04-01), None
patent: WO 2004/031414 (2004-04-01), None
patent: WO 2004/048938 (2004-06-01), None
patent: 2005108603 (2005-11-01), None
Konety et al (Journal of Urology, Feb. 2001, 165:600-611).
GenBank Accession No. NM—014554 (NCBI Sequence Viewer, p. 1-6).
GenBank Accession No. NM—014554 (NCBI Sequence Viewer, printed Jun. 3, 2008, p. 1-6).
Stein et al (Cancer Research, Apr. 2004, 64:2805-2816).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, 4 pages).
Dermer (Bio/Technology, 1994, 12:320).
Shariat et al (Reviews in Urology, 2008, 10:120-135).
Weikert et al (Int J Cancer, 2005, 117:274-280).
Hanke et al (Clinical Chemistry, 2007, 53:2070-2077).
Dey, Pranab; “Urinary markers of bladder carcinoma”; 2004,Clinica Chimica Acta,vol. 340, pp. 57-65.
Gong, Limin et al.; “Differential Regulation of Sentrinized Proteins by a Novel Sentrin-Specific Protease”; 2000,The Journal of Biological Chemistry,vol. 275, No. 5, pp. 3355-3359.
Reesink-Peters, N. et al.; “Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia”; 2003,J. Clin. Pathol.vol. 56, pp. 31-35.
Villalva, Claire et al.; “Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma”; 2002,British Journal of Haematologyvol. 118, pp. 791-798.
Wege, Henning et al.; “SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase”; 2003,Nucleic Acids Research,vol. 31, No. 2 e3, 7 pages.
Wright, Woodring E. et al.; “Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity”; 1995,Nucleic Acids Research,vol. 23, No. 18, pp. 3794-3795.
Search Report, PCT/EP2005/004839, Apr. 5, 2005.
Botezatu, Irina et al.; “Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism”; 2000,Clinical Chemistry,vol. 46, No. 8, pp. 1078-1084.
Bryzgunova, Olga E. et al.; “Isolation and Comparative Study of Cell-Free Nucleic Acids from Human Urine”; 2006,Ann. N.Y. Acad. Sci.,vol. 1075, pp. 334-340.
Cheng, Jinke et al.; “SENP1 Enhances Androgen Receptor-Dependent Transcription through Desumoylation of Histone Deacetylase 1”; 2004,Molecular and Cellular Biology,vol. 24, No. 13, pp. 6021-6028.
Dolicanin, Zana et al.; “Biomarkers for Detection, Treatment Decision and Prognosis of the Urinary Bladder Cancer”; 2007,Medicine and Biology,vol. 14, No. 1, pp. 1-5.
Giannopoulos, Aris et al.; “Comparative Evaluation of the BTAstat Test, NMP22, and Voided Urine Cytology in the Detection of Primary and Recurrent Bladder Tumors”; 2000,Urology,vol. 55, No. 6, pp. 871-875.
Landman, Jaime et al.; “Sensitivity and Specificity of NMP-22, Telomerase, and BTA in the Detection of Human Bladder Cancer”; 1998,Urology,vol. 52, No. 3, pp. 398-402.
Lo, Dennis Y.M.; “Molecular Testing of Urine: Catching DNA on the Way Out”; 2000,Clinical Chemistry,vol. 46, No. 8, pp. 1039-1040.
Hanke, Merle et al.; “Detailed Technocal Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer”; 2007,Clinical Chemistry,vol. 53, No. 12, pp. 2070-2077.
Hewitt, Stephen M. et al.; “Discovery of Protein Biomarkers for Renal Diseases”; 2004,J Am Soc Nephrol.,vol. 15, pp. 1677-1689.
Holyoake, Andrew et al.; “Development of a Multiplex RNA Urine Test for the Detection and Stratification of Transitional Cell Carcinoma of the Bladder”; 2008,Clinical Cancer Research,vol. 14, pp. 742-749.
Ito, Hideaki et al.; “Detection of Human Telomerase Reverse Transcriptase Messenger RNA in Voided Urine Samples as a Useful Diagnostic Tool for Bladder Cancer”; 1998,Clinical Cancer Research,vol. 4, pp. 2807-2810.
Kavaler, Elizabeth et al.; “Detecting Human Bladder Carcinoma Cells in Voided Urine Samples by Assaying for the Presence of Telomerase Activity”; 1998,Cancer,vol. 82, No. 4, pp. 708-714.
Kim, Nam W. et al.; “Specific Association of Human Telomerase Activity with Immortal Cells and Cancer”; 1994,Science,vol. 266, pp. 2011-2015.
Muller, Markus et al.; “Comparison of Human Telomerase RNA and Telomerase Activity in Urine for Diagnosis of Bladder Cancer”; 1998,Clinical Cancer Research,vol. 4, pp. 1949-1954.
Muller, Markus et al.; “Telomerase: Its clinical relevance in the diagnosis of bladder cancer”; 2002,Oncogene,vol. 21, pp. 650-655.
Ramakumar, Sanjay et al.; “Comparison of Screening Methods in the Detection of Bladder Cancer”; 1999,The Journal of Urology,vol. 161, pp. 388-394.
Tinzl, Martina et al.; “DD3PCA3RNA Analysis in Urine—A New Perspective for Detecting Prostate Cancer”; 2004,European Urology,vol. 46, pp. 182-187.
Weiner, H.G. et al.; “Can Urine Bound Diagnostic Tests Replace Cystoscopy in the Management of Bladder Cancer”; 1998,The Journal of Urology,vol. 59, pp. 1876-1880.
Shay, J. W. et al.; “A Survey of Telomerase Activity in Human Cancer”; 1997,European Journal of Cancer,vol. 33, No. 5, pp. 787-791.
Yokota, Jun et al.; 1998,Illustrated Medicine and Science Series, Solving the Mechanisms of Canceration, First Edition,pp. 90-95.
Adachi, Hiroyuki et al.; “Niban gene is commonly expressed in the renal tumors: a new candidate marker for renal carcinogenesis”; 2004,Oncogene,vol. 23, pp. 3495-3500.
European Search Report dated Oct. 22, 2010, issued in related European Patent Application No. 10175616.1.
Higuchi Russell
Holcomb Cherie
Goddard Laura B
Kilpatrick Townsend & Stockton LLP
Roche Molecular Systems Inc.
LandOfFree
SENP1 as a marker for cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with SENP1 as a marker for cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and SENP1 as a marker for cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2657590